Skip to main content
MYUNGMOON PHARM CO.,LTD logo

MYUNGMOON PHARM CO.,LTD — Investor Relations & Filings

Ticker · 017180 ISIN · KR7017180001 KO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2020-05-13 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 017180

About MYUNGMOON PHARM CO.,LTD

http://mmpharm.co.kr/en/main/

Myungmoon Pharm Co., Ltd. is a research-based pharmaceutical company engaged in the development, manufacturing, and commercialization of healthcare products. The company produces over 250 specialized and general medicines, holding more than 400 manufacturing licenses. Its portfolio includes both ethical (ETC) and over-the-counter (OTC) drugs, with key product areas in anesthetics, digestive agents, and antitussives. The company's operations encompass the wholesale, import, and export of its pharmaceutical products for domestic and international markets.

Recent filings

Filing Released Lang Actions
유상증자신주발행가액(안내공시)
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Myungmoon Pharm regarding the 'New Share Issuance Price' (유상증자 신주발행가액) for a capital increase (rights offering). It details the calculation methodology for the issuance price, including the 1st and 2nd issuance price formulas and the final determination process. This falls under the category of capital structure changes and share issuance announcements.
2020-05-13 Korean
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Services Commission in South Korea. It details a capital increase (rights offering) for Myungmoon Pharm Co., Ltd. The document explicitly lists '1st Issue Price Determination' (1차 발행가액 확정) as the reason for the amendment, providing updated financial figures, share prices, and capital usage plans. This type of regulatory filing for capital raising and price adjustments falls under the 'Share Issue/Capital Change' category.
2020-05-13 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from a Korean company (Myungmoon Pharm) detailing a 'Capital Increase Decision' (유상증자결정). It explicitly lists previous filings and provides updated details regarding the issuance price and use of funds. This falls under the category of announcements regarding new share issues or capital changes.
2020-05-13 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Myungmoon Pharm Co., Ltd. for the period ending March 31, 2020. It contains detailed financial information, business descriptions, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-11 Korean
[기재정정]증권신고서(지분증권)
Regulatory Filings Classification · 95% confidence The document is a 'Securities Registration Statement' (증권신고서) filed by Myungmoon Pharm Co., Ltd. It details amendments (정정신고) to a previously filed registration statement to incorporate updated financial data from the Q1 2020 report. This type of document is a regulatory filing related to capital raising and securities issuance, which falls under the 'Regulatory Filings' category as it is a formal legal submission to the financial regulator.
2020-05-11 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) specifically regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the purpose of the capital raise, share issuance details, subscription methods, and timelines. This is a formal regulatory filing in Korea (DART system) concerning changes to capital structure and share issuance, which falls under the 'Share Issue/Capital Change' category.
2020-04-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.